<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In this study, we investigated the <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein expression of S100A2 and S100A4 in <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> of the stomach and esophagus </plain></SENT>
<SENT sid="1" pm="."><plain>Real-time reverse transcription-polymerase reaction analysis on 72 tumors revealed frequent overexpression of S100A2 and S100A4 in Barrett's <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> (BAs) (P &lt; .01) </plain></SENT>
<SENT sid="2" pm="."><plain>Immunohistochemical analysis on <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue microarrays that contained 187 tumors showed absent to weak staining for S100A2 in <z:hpo ids='HP_0000001'>all</z:hpo> <z:mpath ids='MPATH_458'>normal</z:mpath> gastric mucosa samples, whereas <z:mpath ids='MPATH_458'>normal</z:mpath> esophageal mucosa samples demonstrated moderate to strong nuclear staining </plain></SENT>
<SENT sid="3" pm="."><plain>Contrary to the nuclear expression of S100A2 in <z:mpath ids='MPATH_458'>normal</z:mpath> esophageal mucosa, two thirds of Barrett's <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and BAs that overexpressed S100A2 demonstrated stronger cytosolic staining than nuclear staining (P &lt; .001) </plain></SENT>
<SENT sid="4" pm="."><plain>Overexpression of S100A2 protein was more frequently seen in well-differentiated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> than in others (P = .02) </plain></SENT>
<SENT sid="5" pm="."><plain>Moderate to strong staining of S100A4 was detected in two thirds of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> and was frequently observed in the presence of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (P = .02) </plain></SENT>
<SENT sid="6" pm="."><plain>Similar to S100A2, the expression of S100A4 was predominantly cytosolic in two thirds of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (P = .001) </plain></SENT>
<SENT sid="7" pm="."><plain>There was a significant correlation between S100A4 overexpression and lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (<z:chebi fb="0" ids="17997">N(2)</z:chebi>-N(4)) (P = .027) </plain></SENT>
<SENT sid="8" pm="."><plain>These results demonstrate frequent cytosolic overexpression of S100A2 and S100A4 in BAs </plain></SENT>
<SENT sid="9" pm="."><plain>Further studies are ongoing to understand the biological significance of these S100A proteins in Barrett's <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
</text></document>